Pacemaker Impact on TAVR Recovery Costs & Outcomes

Introduction Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive alternative to surgical aortic valve replacement (SAVR), particularly for high-risk patients. However, one significant post-procedural concern is the need for permanent pacemaker implantation (PPM). This article explores the impact of PPM on hospital resource utilization and Medicare reimbursement over a 12-month period.

Key Findings from the Study

  • Prevalence of PPM: 14.8% of Medicare beneficiaries (MBs) who underwent TAVR required a pacemaker during their index hospitalization.
  • Hospital Readmission Rates: 46% of patients were readmitted at least once within a year, with 54.6% of those readmissions occurring within 90 days of discharge.
  • Financial Impact:
    • Average total Medicare reimbursement for all hospitalizations within 12 months was $60,638 ± $28,974.
    • Patients requiring a PPM had significantly higher Medicare reimbursements ($5,132 more) than those who did not.
  • Hospital Length of Stay (LOS):
    • MBs receiving a PPM had a 1.8-day longer total hospital LOS compared to non-PPM patients.

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article